Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (351)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
16
2024
217
6.060
 Why?
Breast Neoplasms
27
2026
2365
4.240
 Why?
Antineoplastic Agents
23
2023
2201
2.360
 Why?
Immunoconjugates
7
2023
138
2.340
 Why?
Antineoplastic Combined Chemotherapy Protocols
20
2025
1961
2.220
 Why?
Pyrimidines
9
2021
519
2.170
 Why?
Protein Kinase Inhibitors
11
2025
971
1.700
 Why?
Piperazines
5
2023
378
1.580
 Why?
Paclitaxel
6
2022
256
1.480
 Why?
Camptothecin
9
2023
138
1.460
 Why?
Neoplasms
15
2026
2873
1.460
 Why?
Pyrazoles
6
2021
512
1.230
 Why?
Ovarian Neoplasms
5
2025
589
1.220
 Why?
Quinoxalines
2
2020
64
1.210
 Why?
Azepines
3
2020
106
1.140
 Why?
Histone Deacetylase Inhibitors
4
2024
218
1.110
 Why?
Antibodies, Monoclonal, Humanized
10
2024
990
1.110
 Why?
Cyclin-Dependent Kinase 4
2
2018
53
1.010
 Why?
Cyclin-Dependent Kinase 6
2
2018
49
1.000
 Why?
Carcinoma, Lobular
3
2026
55
0.840
 Why?
Neutropenia
4
2022
155
0.810
 Why?
Benzoxazoles
2
2021
19
0.800
 Why?
Xenograft Model Antitumor Assays
12
2026
925
0.730
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1437
0.720
 Why?
Maximum Tolerated Dose
10
2026
211
0.690
 Why?
Breast Neoplasms, Male
2
2018
29
0.680
 Why?
beta Catenin
2
2020
252
0.680
 Why?
Female
59
2026
78304
0.670
 Why?
Receptors, Estrogen
3
2021
400
0.630
 Why?
Chemotherapy, Adjuvant
4
2023
427
0.630
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
152
0.630
 Why?
Cancer Care Facilities
1
2020
48
0.630
 Why?
Tumor Microenvironment
5
2026
729
0.610
 Why?
Nuclear Proteins
3
2026
741
0.610
 Why?
eIF-2 Kinase
1
2019
29
0.600
 Why?
Humans
70
2026
144671
0.580
 Why?
Anthracyclines
3
2023
49
0.560
 Why?
Pyridines
5
2025
603
0.560
 Why?
Taxoids
3
2023
116
0.550
 Why?
Aged
27
2026
25955
0.540
 Why?
Aurora Kinase A
4
2020
61
0.520
 Why?
Carcinoma, Ductal, Breast
1
2018
88
0.520
 Why?
Wnt Signaling Pathway
1
2019
210
0.520
 Why?
Drug Resistance, Neoplasm
4
2020
881
0.510
 Why?
Trastuzumab
4
2023
117
0.510
 Why?
Pyrazines
2
2018
92
0.490
 Why?
Aromatase Inhibitors
3
2025
74
0.490
 Why?
Colonic Neoplasms
1
2018
256
0.480
 Why?
Myocardial Infarction
1
2023
1209
0.460
 Why?
Cell Line, Tumor
11
2026
3523
0.460
 Why?
Tumor Suppressor Protein p53
4
2024
532
0.460
 Why?
Angiopoietin-1
1
2015
12
0.450
 Why?
Angiopoietin-2
1
2015
15
0.450
 Why?
Neoplasm Recurrence, Local
5
2025
1145
0.440
 Why?
Neoadjuvant Therapy
1
2018
464
0.440
 Why?
Middle Aged
28
2026
35971
0.410
 Why?
Medicare
4
2023
899
0.400
 Why?
Uterine Cervical Neoplasms
1
2017
269
0.400
 Why?
Bridged-Ring Compounds
2
2023
31
0.390
 Why?
Adult
29
2026
40489
0.380
 Why?
Colorectal Neoplasms
5
2022
849
0.380
 Why?
Dose-Response Relationship, Drug
6
2022
2019
0.380
 Why?
Tumor Suppressor Proteins
1
2015
319
0.370
 Why?
Cell Proliferation
8
2020
2489
0.370
 Why?
Proto-Oncogene Proteins c-met
1
2013
76
0.370
 Why?
Quinolines
4
2025
192
0.370
 Why?
Lung Neoplasms
3
2026
2660
0.370
 Why?
Antibodies, Monoclonal
4
2024
1505
0.370
 Why?
Recombinant Fusion Proteins
1
2015
667
0.360
 Why?
Radiosurgery
3
2025
398
0.360
 Why?
Point Mutation
1
2013
242
0.360
 Why?
Treatment Outcome
13
2025
11735
0.360
 Why?
Antineoplastic Agents, Immunological
3
2019
201
0.360
 Why?
Neoplasm Metastasis
5
2026
691
0.350
 Why?
Triazoles
1
2013
184
0.350
 Why?
Angiogenesis Inhibitors
3
2018
238
0.340
 Why?
Mice, Nude
6
2020
677
0.330
 Why?
Aged, 80 and over
10
2025
8284
0.320
 Why?
Clinical Trials, Phase I as Topic
2
2020
50
0.320
 Why?
Carcinoma, Renal Cell
1
2013
234
0.320
 Why?
Mitochondria
1
2017
984
0.310
 Why?
Histones
3
2023
663
0.310
 Why?
Heart Failure
1
2023
2324
0.310
 Why?
Genes, BRCA2
1
2009
33
0.310
 Why?
Adaptor Proteins, Signal Transducing
2
2026
426
0.300
 Why?
Genes, BRCA1
1
2009
45
0.300
 Why?
Molecular Targeted Therapy
3
2019
437
0.290
 Why?
Biomarkers, Tumor
2
2014
1319
0.290
 Why?
Apoptosis
7
2024
2397
0.290
 Why?
BRCA2 Protein
1
2009
68
0.290
 Why?
Pregnancy Complications, Neoplastic
1
2009
63
0.290
 Why?
Thrombophilia
1
2009
89
0.280
 Why?
Kidney Neoplasms
1
2013
412
0.280
 Why?
Neoplasm Staging
5
2021
1465
0.280
 Why?
Mice
12
2026
18261
0.280
 Why?
Receptors, Progesterone
2
2021
243
0.270
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2026
132
0.270
 Why?
Adenine
2
2021
337
0.270
 Why?
DNA-Binding Proteins
1
2015
1484
0.260
 Why?
Aminopyridines
3
2026
129
0.240
 Why?
Nicotinamide Phosphoribosyltransferase
1
2026
8
0.240
 Why?
Models, Biological
1
2014
1811
0.240
 Why?
Cell Cycle Proteins
3
2026
628
0.230
 Why?
Selective Estrogen Receptor Modulators
1
2025
34
0.230
 Why?
Doxorubicin
3
2024
398
0.220
 Why?
Cardiorespiratory Fitness
1
2025
74
0.220
 Why?
Animals
15
2026
37948
0.210
 Why?
Biopsy
3
2018
1079
0.210
 Why?
Cyclophosphamide
2
2018
265
0.200
 Why?
DNA Repair
1
2026
256
0.200
 Why?
Trans-Activators
1
2026
397
0.200
 Why?
Wound Healing
1
2026
352
0.190
 Why?
Disease Models, Animal
3
2021
4539
0.190
 Why?
Brain Neoplasms
3
2025
1327
0.190
 Why?
United States
5
2023
16018
0.190
 Why?
Liver Neoplasms
1
2009
777
0.190
 Why?
Cyclin-Dependent Kinase 9
1
2022
18
0.180
 Why?
Histone Deacetylase 1
1
2022
23
0.180
 Why?
Aurora Kinases
2
2012
28
0.180
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
44
0.180
 Why?
Topoisomerase I Inhibitors
2
2022
19
0.170
 Why?
Administration, Oral
3
2022
851
0.170
 Why?
Disease Progression
4
2019
2847
0.170
 Why?
Fluorouracil
1
2022
234
0.170
 Why?
Acetylation
1
2022
249
0.170
 Why?
Androstadienes
1
2021
75
0.170
 Why?
Biliary Tract Neoplasms
1
2021
31
0.160
 Why?
Arrhythmias, Cardiac
1
2023
355
0.160
 Why?
Drug Administration Schedule
3
2017
779
0.160
 Why?
Heterografts
1
2021
143
0.160
 Why?
Carboplatin
1
2021
161
0.160
 Why?
Diarrhea
2
2019
192
0.160
 Why?
Hospitals, University
1
2021
176
0.160
 Why?
Male
16
2026
72431
0.160
 Why?
Necrosis
2
2019
243
0.160
 Why?
Histone Deacetylases
1
2022
207
0.160
 Why?
Cancer Survivors
1
2025
330
0.160
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
62
0.160
 Why?
Fatigue
2
2022
363
0.150
 Why?
Immunotherapy
2
2023
662
0.150
 Why?
Immune System
1
2021
178
0.150
 Why?
Clinical Trials as Topic
3
2016
1056
0.150
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
39
0.150
 Why?
Benzodiazepines
1
2021
168
0.150
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
138
0.150
 Why?
Corneal Ulcer
1
1999
20
0.150
 Why?
Kaplan-Meier Estimate
1
2021
967
0.140
 Why?
Tumor Cells, Cultured
1
2020
881
0.140
 Why?
Albumins
1
2019
119
0.140
 Why?
Aquaporin 4
1
2019
98
0.140
 Why?
Maintenance Chemotherapy
1
2018
42
0.140
 Why?
Sucrase
1
1998
2
0.140
 Why?
Vascular Endothelial Growth Factor A
2
2018
550
0.140
 Why?
Cytokines
1
2026
2045
0.140
 Why?
Microvilli
1
1998
75
0.140
 Why?
Cornea
1
1999
154
0.140
 Why?
Nausea
1
2018
112
0.130
 Why?
Mice, Inbred BALB C
1
2020
1251
0.130
 Why?
Drug Therapy, Combination
1
2020
1044
0.130
 Why?
Breast
1
2018
157
0.130
 Why?
Antibodies, Bispecific
1
2018
69
0.130
 Why?
Radiotherapy, Adjuvant
1
2018
223
0.130
 Why?
Purines
1
2018
187
0.130
 Why?
Benzimidazoles
1
2018
187
0.130
 Why?
Topotecan
1
2017
17
0.130
 Why?
Bacterial Infections
1
1999
247
0.130
 Why?
Isoflavones
1
2017
25
0.130
 Why?
Calcium-Binding Proteins
1
2018
222
0.130
 Why?
Imidazoles
1
2018
246
0.130
 Why?
Survival Analysis
1
2020
1370
0.130
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
23
0.130
 Why?
Carbolines
1
2017
35
0.130
 Why?
Mastectomy
1
2018
174
0.120
 Why?
Inhibitory Concentration 50
2
2016
90
0.120
 Why?
Programmed Cell Death 1 Receptor
1
2019
264
0.120
 Why?
Hypertension
2
2018
1262
0.120
 Why?
Cell Survival
1
2019
1092
0.120
 Why?
Insulin-Like Growth Factor I
1
2018
317
0.120
 Why?
Neoplasms, Radiation-Induced
1
2016
100
0.120
 Why?
Retrospective Studies
4
2025
17149
0.120
 Why?
GPI-Linked Proteins
1
2016
81
0.110
 Why?
Neoplasms, Second Primary
1
2016
101
0.110
 Why?
Tumor Protein p73
1
2015
18
0.110
 Why?
Antibodies, Neoplasm
1
2015
34
0.110
 Why?
Phosphorylation
1
2019
1704
0.110
 Why?
Risk Reduction Behavior
1
2016
215
0.110
 Why?
Carcinoma, Non-Small-Cell Lung
1
2024
1186
0.110
 Why?
Hodgkin Disease
1
2016
171
0.110
 Why?
Nanoparticles
1
2021
512
0.110
 Why?
Oxazoles
2
2025
48
0.110
 Why?
Maytansine
1
2014
18
0.110
 Why?
Demography
1
2015
287
0.100
 Why?
Brain Edema
1
2014
62
0.100
 Why?
Protein Kinases
1
2015
314
0.100
 Why?
Drug Interactions
1
2015
401
0.100
 Why?
Survival Rate
2
2019
2089
0.100
 Why?
Exercise
1
2025
2183
0.100
 Why?
Threonine
1
2013
44
0.100
 Why?
Sulfones
1
2014
127
0.100
 Why?
Tumor Stem Cell Assay
1
2012
34
0.090
 Why?
Quinazolines
2
2025
266
0.090
 Why?
Drug Evaluation, Preclinical
1
2013
195
0.090
 Why?
Randomized Controlled Trials as Topic
1
2019
1742
0.090
 Why?
Glycine
1
2014
186
0.090
 Why?
Diabetes Mellitus, Type 2
2
2025
2573
0.090
 Why?
Bacteria
1
1999
894
0.090
 Why?
Drug Design
1
2013
176
0.090
 Why?
Time Factors
2
2020
7140
0.090
 Why?
Methionine
1
2013
162
0.090
 Why?
Heterozygote
1
2013
313
0.090
 Why?
Intestinal Mucosa
1
1998
675
0.090
 Why?
In Situ Hybridization, Fluorescence
1
2013
323
0.090
 Why?
Treatment Failure
1
2013
365
0.090
 Why?
Analgesics, Opioid
1
2021
1142
0.090
 Why?
Disease-Free Survival
1
2014
768
0.090
 Why?
Neovascularization, Pathologic
1
2013
284
0.090
 Why?
Cell Transformation, Neoplastic
1
2013
337
0.080
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
230
0.080
 Why?
Cluster Analysis
1
2012
516
0.080
 Why?
Carcinoma in Situ
1
2011
44
0.080
 Why?
Computational Biology
1
2015
681
0.080
 Why?
Risk Assessment
1
2020
3729
0.080
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
86
0.080
 Why?
Risk Factors
2
2025
10796
0.080
 Why?
Colorado
1
2020
4558
0.080
 Why?
Cellular Senescence
1
2012
223
0.080
 Why?
Mutation
2
2012
4081
0.080
 Why?
Sequence Analysis, DNA
1
2013
828
0.080
 Why?
Gastric Emptying
1
2009
36
0.070
 Why?
Tumor Burden
1
2010
324
0.070
 Why?
Keratinocytes
1
2010
250
0.070
 Why?
Pregnancy Trimester, Second
1
2009
80
0.070
 Why?
Enteric Nervous System
1
2009
26
0.070
 Why?
Stomach
1
2009
109
0.070
 Why?
Mastectomy, Segmental
1
2009
107
0.070
 Why?
Pregnancy Trimester, First
1
2009
136
0.070
 Why?
Apoptosis Regulatory Proteins
1
2009
185
0.070
 Why?
Muscle, Smooth
1
2009
153
0.070
 Why?
Lymph Node Excision
1
2009
173
0.070
 Why?
Diabetes Mellitus, Experimental
1
2009
185
0.070
 Why?
Risk
1
2009
911
0.060
 Why?
Cell Adhesion Molecules
2
2019
178
0.060
 Why?
Infusions, Intravenous
2
2019
422
0.060
 Why?
Pentosyltransferases
1
2026
6
0.060
 Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
1
2026
15
0.060
 Why?
Antigens, Neoplasm
2
2019
272
0.060
 Why?
Phosphodiesterase 4 Inhibitors
1
2026
12
0.060
 Why?
Prognosis
2
2018
4312
0.060
 Why?
Cyclopropanes
1
2026
83
0.060
 Why?
Acrylamides
1
2026
73
0.060
 Why?
Gene Expression Profiling
1
2012
1766
0.060
 Why?
Phthalazines
1
2026
63
0.060
 Why?
Cyclic AMP Response Element-Binding Protein
1
2026
145
0.060
 Why?
CD8-Positive T-Lymphocytes
2
2023
915
0.050
 Why?
Alveolar Epithelial Cells
1
2026
120
0.050
 Why?
Benzamides
1
2026
224
0.050
 Why?
Accelerometry
1
2025
118
0.050
 Why?
Cell Cycle
2
2018
595
0.050
 Why?
Combined Modality Therapy
2
2019
1268
0.050
 Why?
Mesylates
1
2022
7
0.050
 Why?
Follow-Up Studies
2
2025
5414
0.050
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
68
0.050
 Why?
Signal Transduction
2
2014
5185
0.050
 Why?
Oxygen Consumption
1
2025
717
0.050
 Why?
Clinical Protocols
1
2023
282
0.040
 Why?
Ligands
1
2024
662
0.040
 Why?
RNA, Small Interfering
1
2024
631
0.040
 Why?
Chimerism
1
2021
34
0.040
 Why?
Lymphocyte Subsets
1
2021
79
0.040
 Why?
Lymphoid Tissue
1
2021
78
0.040
 Why?
Blood Glucose
3
2025
2326
0.040
 Why?
Liver
1
2009
1889
0.040
 Why?
Mice, SCID
1
2021
368
0.040
 Why?
Hormones
1
2020
133
0.040
 Why?
SEER Program
1
2021
226
0.040
 Why?
Mice, Inbred NOD
1
2021
610
0.040
 Why?
Bacteriological Techniques
1
1999
68
0.040
 Why?
Immunohistochemistry
2
2016
1705
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Monosaccharide Transport Proteins
1
1998
56
0.030
 Why?
Tissue Distribution
1
2018
335
0.030
 Why?
Infant, Newborn
1
2009
6399
0.030
 Why?
Anemia
1
2019
189
0.030
 Why?
Insulin Resistance
1
2025
1241
0.030
 Why?
Intestine, Small
1
1998
167
0.030
 Why?
Biological Transport
1
1998
418
0.030
 Why?
Pregnancy
1
2009
7122
0.030
 Why?
In Vitro Techniques
1
1998
1046
0.030
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
106
0.030
 Why?
Cetuximab
1
2016
111
0.030
 Why?
Retreatment
1
2016
77
0.030
 Why?
Neoplasm Transplantation
1
2016
246
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
190
0.030
 Why?
Carotid Artery Diseases
1
1996
70
0.030
 Why?
Platinum
1
2016
50
0.030
 Why?
Arterial Occlusive Diseases
1
1996
90
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
254
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
677
0.030
 Why?
History, Ancient
1
2015
55
0.030
 Why?
Transcription Factors
1
2023
1726
0.030
 Why?
C-Peptide
1
1996
190
0.030
 Why?
Carotid Arteries
1
1996
207
0.030
 Why?
Femoral Artery
1
1996
190
0.030
 Why?
Kinetics
1
1998
1603
0.030
 Why?
Databases, Genetic
1
2015
247
0.030
 Why?
Diabetic Angiopathies
1
1996
262
0.030
 Why?
Biomarkers
2
2016
4261
0.030
 Why?
DNA Damage
1
2017
430
0.030
 Why?
Mice, Knockout
1
2021
3109
0.030
 Why?
Cross-Sectional Studies
1
2025
5870
0.020
 Why?
Quality of Life
1
2025
3183
0.020
 Why?
Phenotype
1
2021
3147
0.020
 Why?
Glucose
1
1998
1033
0.020
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
259
0.020
 Why?
Tomography, X-Ray Computed
2
2016
2754
0.020
 Why?
Opioid-Related Disorders
1
2021
601
0.020
 Why?
Drug Combinations
1
2013
393
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
454
0.020
 Why?
Lipids
1
1996
706
0.020
 Why?
Biopsy, Needle
1
2011
184
0.020
 Why?
Proto-Oncogene Proteins
1
2014
619
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Enzyme Inhibitors
1
2014
820
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
431
0.020
 Why?
Transcription, Genetic
1
2017
1468
0.020
 Why?
Cohort Studies
1
2021
5957
0.020
 Why?
ErbB Receptors
1
2013
632
0.020
 Why?
Ki-67 Antigen
1
2010
117
0.020
 Why?
Capillary Permeability
1
2010
132
0.020
 Why?
Gastrointestinal Motility
1
2009
29
0.020
 Why?
Patient Selection
1
2013
727
0.020
 Why?
Biological Clocks
1
2009
48
0.020
 Why?
Patient Satisfaction
1
2013
707
0.020
 Why?
Tomography, Emission-Computed, Single-Photon
1
2009
104
0.020
 Why?
Microscopy, Electron
1
2009
413
0.020
 Why?
Membrane Proteins
1
2015
1159
0.020
 Why?
Positron-Emission Tomography
1
2010
343
0.020
 Why?
Rats, Wistar
1
2009
449
0.020
 Why?
Algorithms
1
2015
1844
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3888
0.010
 Why?
Insulin
1
1996
2502
0.010
 Why?
Adolescent
1
2024
22409
0.010
 Why?
Brain
1
2014
2934
0.010
 Why?
Rats
1
2009
5570
0.010
 Why?
Young Adult
1
2014
14122
0.010
 Why?
Tunica Media
1
1996
37
0.010
 Why?
Cholesterol, HDL
1
1996
199
0.010
 Why?
Fasting
1
1996
275
0.010
 Why?
Cholesterol
1
1996
404
0.010
 Why?
Regression Analysis
1
1996
998
0.010
 Why?
Ultrasonography
1
1996
776
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (351) concept(s)
_
Co-Authors Expand Description
See all (74) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)